Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ADAPYADAPY
5 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

GOLDMAN SACHS GROUP INC previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$8,705

Total Shares Change

-16,160

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.03
0
2025-Q3
New
12,320
-
$1,6020.0%$0.14
17
2025-Q2
Exited
0
-100.0%
$00.0%$0.25
0
2025-Q1
Decreased
16,149
-0.1%
$3,1810.0%$0.21
0
2024-Q4
New
16,160
-
$8,7050.0%$0.55
26

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used